We thank Celgene for providing an unrestricted educational grant which made possible these updates from Stockholm.
Updates will be posted daily as the workshop proceeds. Use the links below to get to the daily update pages.
- The workshop opened on Wednesday. The official opening was preceded by a symposium on the biological significance of CD20+ cells in MM and the potential role of therapy targeted at these cells.
Thursday’s topics included full sessions on the biology of MM, abstract presentations of immune, conventional and new therapies and a symposium on drug resistance and reversibility.
Friday's sessions included presentations on conventional and new chemotherapies and transplantation, abstracts on MM biology and a symposium on the therapeutic role of interferon.
Saturday’s sessions include myeloma bone disease, bisphosphonate therapy and idiotype immunity, and abstracts and a symposium on transplantation.
- The workshop concluded on Sunday with a session on the role of viruses in MM. The IMF hosted a satellite session at the conclusion of the workshop to continue the dialog on the role of viruses. Drs. Durie, Berenson, Anderson, Kyle, Vescio and Neipel and others participated in the satellite session. This session included new participants, leaders in their respective fields, who joined for this event, including:
- Luc Montagnier of the Institute Pasteur in Paris (who first discovered the AIDS virus, who brought with him electron microscope photos of complex genetic materials found by Drs. Durie and Urnovitz in myeloma patient plasma)
- Howard Urnovitz of the Chronic Illness Research Foundation (a renowkned retrovirus expert, who collaborated with Dr. Durie on his studies of nucleic acids in myeloma patient plasma)
- John Lednicky of Baylor College of Medicine (an expert in SV40 and its relationship to disease)
- Shou-Jiang Gao of the University Of Texas Health Science Center (an infectious disease expert currently looking into KSHV, collaborating with Dr. Berenson)
This satellite session was exciting in that we believe we have formed a powerful, interdisciplinary collaboration that will make significant inroads into understanding the role of viruses in the development of multiple myeloma and the implications of that role for prevention and treatment.